{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:05:37Z","timestamp":1785179137701,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.atherosclerosis.2019.11.022","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T02:19:15Z","timestamp":1574907555000},"page":"127-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Relationship of systemic pentraxin-3 values with coronary plaque components on optical coherence tomography and post-percutaneous coronary intervention outcomes in patients with stable angina pectoris"],"prefix":"10.1016","volume":"292","author":[{"given":"Shigeki","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4098-8231","authenticated-orcid":false,"given":"Keiichi","family":"Hishikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Nakagama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Mizusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7495-673X","authenticated-orcid":false,"given":"Kazuto","family":"Hayasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Yamakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Sagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Hikita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib1","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/01.CIR.0000079173.84669.4F","article-title":"C-reactive protein and lesion morphology in patients with acute myocardial infarction","volume":"108","author":"Sano","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib4","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1182\/blood.V87.5.1862.1862","article-title":"Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites","volume":"87","author":"Introna","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","article-title":"Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility","volume":"23","author":"Garlanda","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yexmp.2014.11.009","article-title":"Differential expression of pentraxin 3 in neutrophils","volume":"98","author":"Razvina","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.10.003","article-title":"Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases","volume":"99","author":"Casula","year":"2017","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/path.2314","article-title":"Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions","volume":"215","author":"Savchenko","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.5551\/jat.12526","article-title":"Different distribution of pentraxin 3 and C-reactive protein in coronary atherosclerotic plaques","volume":"19","author":"Matsuura","year":"2012","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib10","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/01.CIR.0000145167.30987.2E","article-title":"Lipid Assessment Trial Italian Network (Latin) Investigators. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction","volume":"110","author":"Latini","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.ATV.0000252126.48375.d5","article-title":"Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris","volume":"27","author":"Inoue","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.0000044384.41037.43","article-title":"Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography","volume":"107","author":"Tearney","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib13","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/01.CIR.0000159354.43778.69","article-title":"In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography","volume":"111","author":"Jang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib14","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.jacc.2013.05.071","article-title":"In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography","volume":"62","author":"Jia","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The thrombolysis in myocardial infarction (TIMI) trial","volume":"312","author":"TIMI Study Group","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib16","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow","volume":"3","author":"Gibson","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/CIRCINTERVENTIONS.111.962506","article-title":"Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with elective stent implantation","volume":"4","author":"Lee","year":"2011","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib18","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/01.CIR.0000029927.92825.F6","article-title":"Characterization of human atherosclerosis by optical coherence tomography","volume":"106","author":"Yabushita","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib19","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jacc.2011.09.079","volume":"59","author":"Tearney","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib20","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4244\/EIJV6I6A130","article-title":"Assessment of the coronary calcification by optical coherence tomography","volume":"6","author":"Kume","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/CIRCULATIONAHA.114.014704","article-title":"Incidence and clinical significance of poststent optical coherence tomography findings: one-year follow-up study from a multicenter registry","volume":"132","author":"Soeda","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib22","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1136\/hrt.2009.172072","article-title":"Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach","volume":"95","author":"Gonzalo","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib23","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.amjcard.2006.01.031","article-title":"Assessment of coronary arterial thrombus by optical coherence tomography","volume":"97","author":"Kume","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib24","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.atherosclerosis.2007.05.031","article-title":"Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening","volume":"197","author":"Kotooka","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0735-1097(97)00450-6","article-title":"In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia","volume":"31","author":"Kornowski","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib26","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0735-1097(02)01899-5","article-title":"Systemic inflammation in unstable angina is the result of myocardia necrosis","volume":"39","author":"Cusack","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000364996","article-title":"Elevated plasma level of pentraxin-3 predicts in-hospital and 30-day clinical outcomes in patients with non-ST-segment elevation myocardial infarction who have undergone percutaneous coronary intervention","volume":"129","author":"Guo","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib28","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2018.06.027","article-title":"Usefulness of higher levels of cardiac troponin T in patients with stable Angina pectoris to predict risk of acute myocardial infarction","volume":"122","author":"Vavik","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1253\/circj.CJ-13-0329","article-title":"Relationships of elevated systemic pentraxin-3 levels with high-risk coronary plaque components and impaired myocardial perfusion after percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction","volume":"78","author":"Kimura","year":"2014","journal-title":"Circ. J."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/CIRCULATIONAHA.107.749234","article-title":"Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction","volume":"117","author":"Salio","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/CIRCULATIONAHA.108.806547","article-title":"Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis","volume":"120","author":"Norata","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib32","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jcin.2013.04.024","article-title":"Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound","volume":"6","author":"Koga","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2310\/JIM.0b013e31827c2971","article-title":"Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris","volume":"61","author":"Karakas","year":"2013","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib34","doi-asserted-by":"crossref","first-page":"e2204","DOI":"10.4244\/EIJ-D-16-00679","article-title":"Clinical, angiographic, IVUS, and OCT predictors for irregular protrusion after coronary stenting","volume":"12","author":"Bryniarski","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib35","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1253\/circj.CJ-15-1140","article-title":"Impact of culprit plaque and atherothrombotic components on incomplete stent apposition in patients with ST-elevation myocardial infarction treated with everolimus-eluting stents - an OCTAVIA substudy","volume":"80","author":"Bernelli","year":"2016","journal-title":"Circ. J."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib36","doi-asserted-by":"crossref","first-page":"738","DOI":"10.5551\/jat.47167","article-title":"Association of plasma pentraxin-3 level with lipid levels and cardiovascular risk factors in people with No history of lipid-lowering medication: the dong-gu study","volume":"26","author":"Lee","year":"2019","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2019.11.022_bib37","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5551\/jat.26740","article-title":"Deficiency of long pentraxin PTX3 promoted neointimal hyperplasia after vascular injury","volume":"22","author":"Ishino","year":"2015","journal-title":"J. Atheroscler. Thromb."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019315904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019315904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:41:24Z","timestamp":1758156084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019315904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":37,"alternative-id":["S0021915019315904"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.11.022","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship of systemic pentraxin-3 values with coronary plaque components on optical coherence tomography and post-percutaneous coronary intervention outcomes in patients with stable angina pectoris","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}